Lack of the NS 5 B S 282 T mutation in HCV isolates from liver tissue of treatment-naive patients with HCV genotype-1 b infection

@inproceedings{Maimone2015LackOT,
  title={Lack of the NS 5 B S 282 T mutation in HCV isolates from liver tissue of treatment-naive patients with HCV genotype-1 b infection},
  author={Sergio Maimone and Gianluca Tripodi and Cristina Musolino and Irene Cacciola and Teresa Pollicino and Raimondo},
  year={2015}
}
Background: Despite the availability of several direct-acting antivirals (DAAs) specifically inhibiting different HCV proteins, treatment of chronic HCV infection is still a challenge also because of the possible selection of resistant viral variants under DAA therapy. Indeed, only the emergence of viruses resistant to the nucleoside inhibitors of the HCV NS5B polymerase (Pol) has not yet been reported, in spite of the fact that in vitro studies have clearly shown that an S282T amino acid… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 18 references

: do we need resistance testing ?

  • A Osinusi, EG Meissner, YJ Lee
  • Antiviral Res
  • 2014

Guidelines

  • EASL Clinical Practic
  • Management of hepatitis C virus infection. J…
  • 2014
1 Excerpt

NS 5 A inhibitors in the treatment of hepatitis C

  • AL Aloia, S Locarnini, MR Beard
  • J Hepatol
  • 2013

Similar Papers

Loading similar papers…